Diagnostics AI
By
Is Thermo Fisher’s $10B Q2 Surge the Inflection Point for AI-Powered Biopharma? How Will It Reshape the Life Sciences Landscape?
Key Highlights Financial Resilience and Strategic MarginsThermo Fisher Scientific’s Q2 2025 report showcases its fortress-like financial discipline. With…
Can IGC Pharma’s New AI Models Change Alzheimer’s Diagnosis and Drug Discovery for Millions?
New tools unveiled at AAIC 2025 aim to detect Alzheimer’s earlier and faster, even in low-resource settings Key…
Can Personalis and Tempus Leverage AI to Transform Cancer Recurrence Detection for 150,000 Colorectal Patients? Strategic Expansion Deepens MRD Leadership
Key Highlights AI at the Core of Next-Gen Recurrence MonitoringThe expansion of Personalis’ NeXT Personal® MRD test into…
Is Microsoft’s AI Diagnostic Orchestrator the Beginning of the End for Traditional Doctors — With 4X Higher Accuracy Shaking Up Global Healthcare?
Key Highlights Breakthrough in Diagnostic Accuracy with Microsoft’s AIMicrosoft announced its Diagnostic Orchestrator achieved 85.5% accuracy across 304…
95 Pathologists, 11 Hospitals, 1 AI Platform: Can PathAI and Northwestern Medicine Set the Standard for AI-Driven Pathology?
Key Takeaways• 95 pathologists across 11 hospitals to adopt PathAI’s AISight® digital pathology platform, enabling real-time, AI-enhanced diagnostics•…
25 AI-Driven Companies Leading, Top the 2025 Transformation: Are MedTech Giants Like Regeneron, PHC Holdings, and Henry Schein Redefining Global Healthcare?
Key Highlights AI-First Innovation Is No Longer Optional—It’s the Industry Standard The 2025 MedTech leaderboard showcases how artificial…
